Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Mirum Pharmaceuticals's peak revenue was $336.9M in 2024. The peak quarterly revenue was $99.4M in 2024(q4).
Mirum Pharmaceuticals's revenue increased from $19.1m in 2021 to $336.9M currently. That's a 1,660.31% change in annual revenue.
| Fiscal year / year | Mirum Pharmaceuticals revenue |
|---|---|
| 2021 | $19.1M |
| 2022 | $77.1M |
| 2023 | $186.4M |
| 2024 | $336.9M |
Rate Mirum Pharmaceuticals' financial transparency
Mirum Pharmaceuticals saw the greatest revenue growth in 2022, when revenue increased by 302.66%.
Mirum Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by 302.66%.
| Year | Mirum Pharmaceuticals growth |
|---|---|
| 2022 | 303%↑ |
| 2023 | 142%↑ |
| 2024 | 81%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | $11.0M | $5.0M | $3.1M |
| 2022 | $12.9M | $17.5M | $18.8M | $27.9M |
| 2023 | $31.6M | $37.5M | $47.7M | $69.6M |
| 2024 | $69.2M | $77.9M | $90.4M | $99.4M |
Do you work at Mirum Pharmaceuticals?
Did Mirum Pharmaceuticals meet its revenue projections?
| CEO | Christopher Peetz |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 113 |
| Date Founded | 2018 |
| Headquarters | Foster City, California |
| Number of Locations | 1 |
| Revenue | $336.9M |
| Net Income | -$135,665,000 |
| Gross Proft | $255.2M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $352,906,000 |
| Ticker | MIRM |
Mirum Pharmaceuticals received early financing of $120.0M on 2018-11-07.
| Series | Round size | Date |
|---|---|---|
| Series A | $120M | 11/2018 |
| Post Ipo Equity | $10M | 12/2020 |
| Investors | Security type |
|---|---|
| Novo Holdings A | Series A |
| New Enterprise Associates (NEA) | Series A |
| Pappas Ventures | Series A |
| Frazier Healthcare Partners | Series A |
| Chiesi Ventures | Series A |
| Rock Springs Capital | Series A |
| Deerfield Capital Management | Series A |
| RiverVest Venture Management LLC | Series A |
| Oberland Capital | Post Ipo Equity |
Zippia gives an in-depth look into the details of Mirum Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Mirum Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Mirum Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Mirum Pharmaceuticals. The data presented on this page does not represent the view of Mirum Pharmaceuticals and its employees or that of Zippia.
Mirum Pharmaceuticals may also be known as or be related to MIRUM PHARMACEUTICALS, INC., Mirum Pharmaceuticals, Mirum Pharmaceuticals Inc and Mirum Pharmaceuticals, Inc.